In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Travere Therapeutics Inc’s stock clocked out at $14.91, up 0.54% from its previous closing price of $14.83. In other words, the price has increased by $0.54 from its previous closing price. On the day, 1.36 million shares were traded. TVTX stock price reached its highest trading level at $15.23 during the session, while it also had its lowest trading level at $14.54.
Ratios:
To gain a deeper understanding of TVTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.04 and its Current Ratio is at 2.08. In the meantime, Its Debt-to-Equity ratio is 6.80 whereas as Long-Term Debt/Eq ratio is at 5.54.
On October 21, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $9 to $27.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 11 ’25 when Cline Christopher R. sold 48 shares for $13.14 per share. The transaction valued at 631 led to the insider holds 89,990 shares of the business.
Christopher Cline bought 48 shares of TVTX for $631 on Apr 11 ’25. On Feb 12 ’25, another insider, ROTE WILLIAM E., who serves as the SENIOR VICE PRESIDENT, R&D of the company, sold 5,200 shares for $23.53 each. As a result, the insider received 122,356 and left with 98,519 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1323585920 and an Enterprise Value of 1353993856. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.68 while its Price-to-Book (P/B) ratio in mrq is 22.07. Its current Enterprise Value per Revenue stands at 5.807 whereas that against EBITDA is -6.368.
Stock Price History:
The Beta on a monthly basis for TVTX is 0.96, which has changed by 1.4891486 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, TVTX has reached a high of $25.29, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is -23.88%, while the 200-Day Moving Average is calculated to be -6.61%.
Shares Statistics:
It appears that TVTX traded 1.80M shares on average per day over the past three months and 2189890 shares per day over the past ten days. A total of 87.45M shares are outstanding, with a floating share count of 87.44M. Insiders hold about 1.50% of the company’s shares, while institutions hold 109.19% stake in the company. Shares short for TVTX as of 1743379200 were 11556812 with a Short Ratio of 6.42, compared to 1740700800 on 10948550. Therefore, it implies a Short% of Shares Outstanding of 11556812 and a Short% of Float of 13.11.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
